Squarepoint’s Y-mAbs Therapeutics YMAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $55.2K | Sell |
12,233
-116,294
| -90% | -$524K | ﹤0.01% | 2592 |
|
|
2025
Q1 | $569K | Buy |
128,527
+25,559
| +25% | +$113K | ﹤0.01% | 1833 |
|
|
2024
Q4 | $806K | Sell |
102,968
-51,963
| -34% | -$407K | ﹤0.01% | 1662 |
|
|
2024
Q3 | $2.04M | Buy |
154,931
+28,542
| +23% | +$375K | ﹤0.01% | 1120 |
|
|
2024
Q2 | $1.53M | Buy |
126,389
+74,452
| +143% | +$899K | ﹤0.01% | 1182 |
|
|
2024
Q1 | $844K | Buy |
+51,937
| New | +$844K | ﹤0.01% | 1427 |
|
|
2023
Q1 | – | Sell |
-91,143
| Closed | -$445K | – | 2858 |
|
|
2022
Q4 | $445K | Buy |
+91,143
| New | +$445K | ﹤0.01% | 1504 |
|
|
2021
Q3 | – | Sell |
-18,554
| Closed | -$627K | – | 2809 |
|
|
2021
Q2 | $627K | Sell |
18,554
-18,335
| -50% | -$620K | ﹤0.01% | 1473 |
|
|
2021
Q1 | $1.12M | Buy |
36,889
+17,174
| +87% | +$520K | 0.01% | 1009 |
|
|
2020
Q4 | $976K | Buy |
19,715
+4,180
| +27% | +$207K | 0.01% | 1096 |
|
|
2020
Q3 | $596K | Sell |
15,535
-696
| -4% | -$26.7K | 0.01% | 1223 |
|
|
2020
Q2 | $701K | Sell |
16,231
-21,719
| -57% | -$938K | 0.01% | 1120 |
|
|
2020
Q1 | $990K | Sell |
37,950
-34,538
| -48% | -$901K | 0.03% | 723 |
|
|
2019
Q4 | $2.27M | Buy |
72,488
+23,174
| +47% | +$724K | 0.01% | 819 |
|
|
2019
Q3 | $1.29M | Buy |
49,314
+29,614
| +150% | +$772K | 0.01% | 1038 |
|
|
2019
Q2 | $451K | Buy |
+19,700
| New | +$451K | ﹤0.01% | 1684 |
|